Fig. 3From: Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemiaA bar chart showing the number of patients changing TKI by transcript type for all reasons and as a result of treatment failure. Superimposed on this is a line chart showing time to change for each transcript type for all reasons and for treatment failureBack to article page